Cargando…
Key regulators of apoptosis execution as biomarker candidates in melanoma
Resistance to apoptosis is frequently detected in malignant melanoma, a skin cancer with rapidly growing incidence rates. Apoptosis resistance may develop with disease progression and may be associated with the poor responsiveness of metastatic melanoma to apoptosis-inducing treatments, such as geno...
Autores principales: | Charles, Emilie M, Rehm, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904965/ https://www.ncbi.nlm.nih.gov/pubmed/27308353 http://dx.doi.org/10.4161/23723548.2014.964037 |
Ejemplares similares
-
Diffusion is capable of translating anisotropic apoptosis initiation into a homogeneous execution of cell death
por: Huber, Heinrich J, et al.
Publicado: (2010) -
Identification of key candidate genes involved in melanoma metastasis
por: Chen, Jia, et al.
Publicado: (2019) -
Biomarkers as Key Contributors in Treating Malignant Melanoma Metastases
por: de Souza, Camila Ferreira, et al.
Publicado: (2012) -
The apoptosome molecular timer synergises with XIAP to suppress apoptosis execution and contributes to prognosticating survival in colorectal cancer
por: Fullstone, Gavin, et al.
Publicado: (2020) -
Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma
por: Skoko, Josip, et al.
Publicado: (2018)